Medicover AB (publ)

OM:MCOV B Stock Report

Market Cap: SEK 38.5b

Medicover Future Growth

Future criteria checks 5/6

Medicover is forecast to grow earnings and revenue by 29.9% and 11.2% per annum respectively. EPS is expected to grow by 26.9% per annum. Return on equity is forecast to be 23.8% in 3 years.

Key information

29.9%

Earnings growth rate

26.86%

EPS growth rate

Healthcare earnings growth24.9%
Revenue growth rate11.2%
Future return on equity23.76%
Analyst coverage

Good

Last updated28 Sep 2025

Recent future growth updates

Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Jul 27
Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Recent updates

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Sep 24
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing

Sep 01
Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing

Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Jul 27
Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Medicover (STO:MCOV B) Seems To Use Debt Quite Sensibly

Jul 22
Medicover (STO:MCOV B) Seems To Use Debt Quite Sensibly

Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

May 09
Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Apr 28
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Apr 14
Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively

Mar 21
Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively
User avatar

New Investments In India's And Romania's Healthcare Services Will Expand Future Global Reach

Strong cash generation supports debt reduction and further investments, boosting future earnings growth positively.

Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

Dec 12
Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 07
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Oct 24
Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Dec 20
Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Dec 02
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Sep 12
Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Aug 21
Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12
Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27
Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12
Is Medicover (STO:MCOV B) Using Too Much Debt?

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16
Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Earnings and Revenue Growth Forecasts

OM:MCOV B - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20273,0261342013806
12/31/20262,7301001673216
12/31/20252,40673-222756
6/30/20252,25843157281N/A
3/31/20252,17131148271N/A
12/31/20242,09217140262N/A
9/30/20241,99820122240N/A
6/30/20241,91123116225N/A
3/31/20241,82622113222N/A
12/31/20231,7461895205N/A
9/30/20231,682890205N/A
6/30/20231,610575202N/A
3/31/20231,548143186N/A
12/31/20221,5101230170N/A
9/30/20221,4893745182N/A
6/30/20221,4555967195N/A
3/31/20221,4428895205N/A
12/31/20211,377102115217N/A
9/30/20211,29993105202N/A
6/30/20211,2269091176N/A
3/31/20211,07652104176N/A
12/31/20209982683155N/A
9/30/20209301475141N/A
6/30/2020879453122N/A
3/31/20208841631100N/A
12/31/2019844232487N/A
9/30/2019796192879N/A
6/30/2019751193986N/A
3/31/201970920N/A85N/A
12/31/201867222N/A74N/A
9/30/201864328N/A75N/A
6/30/201862026N/A61N/A
3/31/201860023N/A55N/A
12/31/201758019N/A50N/A
9/30/201756010N/A40N/A
6/30/20175409N/A36N/A
3/31/20175226N/A31N/A
12/31/20164974N/A26N/A
12/31/20154168N/A29N/A
12/31/20143654N/A22N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MCOV B's forecast earnings growth (29.9% per year) is above the savings rate (1.6%).

Earnings vs Market: MCOV B's earnings (29.9% per year) are forecast to grow faster than the Swedish market (16.4% per year).

High Growth Earnings: MCOV B's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MCOV B's revenue (11.2% per year) is forecast to grow faster than the Swedish market (5% per year).

High Growth Revenue: MCOV B's revenue (11.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MCOV B's Return on Equity is forecast to be high in 3 years time (23.8%)


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 15:46
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medicover AB (publ) is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
null nullABG Sundal Collier Sponsored
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB